{content}

Study list

PANTHER

United Kingdom
|
2026
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza
  • Pharmacological intervention
  • Immnunomodulator
  • Baricitinib
  • Statins
  • Simvastatin

THALASSA

Spain
|
2025-2026
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Plitidepsin
  • Antineoplastic agent

EU-PROACT

France Norway Spain Belgium Italy United Kingdom Ireland Austria The Netherlands Switzerland
|
2025
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza

Merinero

Spain
|
2024-2025
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

McCracken

United Kingdom
|
2024-2026
  • Adults
  • Elderly
  • Paediatric
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample

Velay

France
|
2024-2025
  • Adults
  • Elderly
  • Travelers
  • Hospital wide
  • Emergency department
  • Arbovirus
  • Vector-borne
  • Chikungunya virus
  • Dengue virus
  • Zika virus
  • Arboviral disease
  • Vector-borne disease

Cathomas

Switzerland
|
2024-2028
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neuromodulation

Hellemons

The Netherlands
|
2024-2026
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Oxygen therapy

EPOXI

Belgium France Germany Italy Norway Portugal Spain The Netherlands
|
2024-2026
  • Adults
  • General population
  • Elderly
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

COCO-Long’Run

France
|
2024-2027
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Cardiac coherence

Kroemer

Germany
|
2024-2027
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

InvidiCO

Germany
|
2024-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Vimida